| 词条 | Pirnabine |
| 释义 |
| Watchedfields = changed | verifiedrevid = 444058373 | IUPAC_name = (3,6,6,9-tetramethyl-7,8,9,10-tetrahydrobenzo[c]chromen-1-yl) acetate | image = Pirnabine_structure.png | width = 200 | tradename = | legal_status = | routes_of_administration = | metabolism = | elimination_half-life = | excretion = | CAS_number = 68298-00-0 | PubChem = 50137 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | UNII_Ref = {{fdacite|correct|FDA}} | UNII = S3FHL03F60 | ChemSpiderID = 45469 | C=19 | H=24 | O=3 | molecular_weight = 300.391 g/mol | smiles = O=C(C)Oc1cc(C)cc(OC2(C)C)c1C(C3)=C2CCC3C | StdInChI = 1S/C19H24O3/c1-11-6-7-15-14(8-11)18-16(21-13(3)20)9-12(2)10-17(18)22-19(15,4)5/h9-11H,6-8H2,1-5H3 | StdInChIKey = AADNQNOXNWEYHS-UHFFFAOYSA-N }}Pirnabine (SP-304) is a synthetic cannabinoid receptor ligand, which was developed for the treatment of glaucoma.[1] References1. ^ {{Cannabinoids}}{{Cannabinoidergics}}{{cannabinoid-stub}} 4 : Cannabinoids|Benzochromenes|Phenols|Acetate esters |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。